Graves’ disease is an autoimmune thyroid condition that causes the gland to be overactive. People with Graves’ disease often notice weight loss, heat intolerance, shaking hands, fast heartbeat, anxiety, and trouble sleeping, and doctors may see an enlarged thyroid or eye changes. It tends to be long term, but treatment can control symptoms and protect long‑term health. It is more common in women and often starts in early to mid‑adulthood, but it can affect all ages. Treatment for Graves’ disease includes anti‑thyroid medicines, radioactive iodine, or surgery, and most people do well with care.
Overview
Graves' diseaseSymptoms
Graves' disease often causes anxiety, heat intolerance, weight loss despite increased appetite, tremor, and a rapid heartbeat. Early symptoms of Graves' disease may include fatigue, sleep problems, loose stools, menstrual changes, neck swelling (goiter), and eye irritation or bulging.
Outlook and prognosis
Most people with Graves’ disease do well with treatment, though it often needs long‑term follow‑up. Symptoms like tremor, heat intolerance, and weight loss usually improve within weeks to months. Eye symptoms may take longer and sometimes need specialized care.
Causes and risk factors
Graves' disease results from an autoimmune response that overstimulates the thyroid. Risk increases with genetic predisposition or family history, female sex, other autoimmune conditions, smoking, major stress, pregnancy/postpartum, high iodine intake, and certain medications or infections.
Genetic influences
Genetics play a meaningful role in Graves’ disease, raising risk when close relatives are affected. Multiple gene variations influence immune regulation and thyroid function. Still, environment—stress, smoking, infections, iodine exposure—and hormones also shape who develops it and when.
Diagnosis
Graves' disease is diagnosed using your history and exam, thyroid blood tests (low TSH, high free T4/T3), and antibodies. A radioactive iodine uptake scan or thyroid ultrasound may confirm the cause, especially when the diagnosis of Graves' disease is unclear.
Treatment and drugs
Graves’ disease treatment aims to calm an overactive thyroid and ease symptoms. Options include antithyroid medicines, beta blockers for rapid heartbeat and tremor, radioactive iodine to shrink thyroid activity, or surgery in selected cases. Eye symptoms may need separate care.
Symptoms
In everyday life, it may feel like your body is stuck on fast-forward—your heart races, you feel too warm, and sleep doesn’t refresh you. Many notice early symptoms of Graves' disease like unexplained weight loss, shaky hands, and nervous energy that’s hard to switch off. Clinicians call this hyperthyroidism, which means your thyroid is making too much hormone. A healthcare professional can check your thyroid and help sort out what’s going on.
Your heart may race even at rest, and you might feel pounding or fluttering in your chest. With Graves' disease, this can show up as a rapid pulse or irregular beats. Shortness of breath can happen with mild activity.
Rooms that feel fine to others can seem too warm, with flushing and extra sweating. In Graves' disease, people often wake sweaty at night or feel overheated during the day.
Many feel on edge, restless, or quick to anger. These mood shifts can make it hard to focus at work or unwind in the evening.
Falling asleep can be hard, and night awakenings are common. Light, broken sleep can leave you tired the next day.
How people usually first notice Graves' disease?
Many people first notice Graves’ disease when their heart races, they feel unusually anxious or shaky, and they can’t tolerate heat, sometimes alongside unexpected weight loss despite eating normally. Others pick up on changes in their eyes—grittiness, dryness, a “staring” look, or mild swelling—or a new fullness in the neck from an enlarged thyroid, which friends or family may point out. These first signs of Graves’ disease often lead to a check-up where a doctor feels the thyroid, checks pulse and reflexes, and confirms hyperthyroidism with blood tests.
Types of Graves' disease
Graves' disease can show up in a few recognizable ways that affect day-to-day life, from how your heart races to how your eyes feel and look. Symptoms don’t always look the same for everyone. Some people mainly notice thyroid-related changes, while others have prominent eye or skin findings, and a smaller group develop changes in the lower legs. Understanding the main types of Graves’ manifestations can help you and your clinician discuss the specific types of Graves’ disease you’re experiencing.
Thyroid overactivity
This is the classic form with an overactive thyroid causing anxiety, heat intolerance, sweating, weight loss, and a fast or irregular heartbeat. You may feel shaky, have trouble sleeping, and notice more frequent bowel movements.
Eye involvement
Eyes can feel gritty or dry, look puffy, or appear more prominent, sometimes with light sensitivity and double vision. For many, certain types stand out more than others.
Skin involvement
A thickened, dimpled skin patch can form on the shins or tops of the feet, often reddish and not usually painful. It can itch or feel tight, and swelling in the area may come and go.
Lower-leg swelling
Some develop firm swelling over the shins due to fluid and tissue changes related to Graves’. Shoes or socks may feel tight, and standing for long periods can make it more noticeable.
What genetics can tell you about symptoms
Certain HLA gene variants, especially HLA-DRB1 and HLA-DQA1, can make your immune system more likely to attack the thyroid, causing symptoms like anxiety, tremor, heat intolerance, and weight loss. Variants near CTLA4 and PTPN22 can intensify this immune misfire, increasing eye irritation or bulging and rapid heartbeat.
Causes and risk factors
Graves' disease happens when the immune system attacks the thyroid by mistake and makes it overactive. Risk is higher with a family history, being female, ages 30 to 50, or other autoimmune diseases. Risk factors do not predict the early symptoms of Graves' disease, but they guide when to check thyroid levels. Smoking, high stress, recent pregnancy or the months after birth, and excess iodine can trigger Graves' disease. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t).
Environmental and biological risk factors
Understanding what raises risk can help you spot early symptoms of Graves' disease and plan care with your doctor. Some risks are carried inside the body, others come from the world around us. Knowing your personal mix of risks can make choices about scans and medicines feel more focused.
People who are female develop autoimmune thyroid overactivity more often. Hormone patterns across the lifespan may raise susceptibility.
The condition most often begins between ages 20 and 50. Immune activity is high in these years, which may add risk.
In the months after delivery, immune defenses rebound and can misfire against the thyroid. This postpartum window can trigger Graves' disease.
People living with another autoimmune condition have higher odds of a second autoimmune thyroid problem. Shared immune pathways raise overall risk.
Genetic risk factors
Graves' disease often runs in families and is linked to a mix of immune-related genes that raise susceptibility. Carrying a genetic change doesn’t guarantee the condition will appear. Specific changes in HLA, CTLA4, PTPN22, and the TSH receptor gene can tilt the immune system toward attacking the thyroid. Knowing your family history may prompt earlier checks if early symptoms of Graves' disease show up.
Family history: Having close relatives with Graves' disease or autoimmune thyroid disease raises your chances. Shared genetics explains most of this pattern.
Polygenic inheritance: No single gene causes this condition on its own. Many small DNA differences add up to increase risk.
HLA class II variants: Changes in immune recognition genes (HLA-DR/DQ) make it easier for the immune system to target the thyroid. These variants are strongly linked to Graves' disease. Specific risk versions can differ by ancestry.
CTLA4 gene changes: Variants in this immune “brake” can reduce its calming effect on T cells. That can make an overactive response to thyroid proteins more likely.
PTPN22 variant: A common change in this immune signaling gene can alter how immune cells are tuned. It has been tied to several autoimmune conditions, including Graves' disease.
TSH receptor gene: Variants near or within the TSH receptor (TSHR) gene can encourage antibodies that overstimulate the thyroid. This is central to the overactive thyroid seen in Graves' disease.
Thyroglobulin gene: Changes in the TG gene can influence how thyroid proteins are processed and shown to the immune system. This can raise the chance of autoimmune targeting.
CD40 pathway genes: Variants in CD40 can boost signals that activate immune cells. Stronger activation may promote antibody production against the thyroid.
IL2RA (CD25): Changes in the interleukin‑2 receptor alpha gene can affect regulatory T cells. Weaker regulation can allow self‑reactive cells to expand.
X-chromosome factors: Differences related to genes on the X chromosome and X-inactivation may influence immune regulation. This may help explain higher rates in people assigned female at birth.
FCRL3 variants: Differences in this B-cell gene can influence how antibody‑producing cells behave. Certain versions are associated with Graves' disease.
Shared autoimmunity genes: Many risk genes overlap with type 1 diabetes, rheumatoid arthritis, and other autoimmune diseases. This shared biology helps explain why Graves' disease can cluster with other autoimmune conditions in some families.
Lifestyle risk factors
Lifestyle habits don’t cause the autoimmune process of Graves’ disease, but they can influence the chance of onset, flare frequency, symptom severity, and complications. Research points to several lifestyle risk factors for Graves’ disease and modifiable habits that can worsen its course. Understanding how lifestyle affects Graves' disease can help you choose changes that support treatment and recovery.
Cigarette smoking is strongly linked to a higher risk of Graves’ disease and to more severe thyroid eye disease. Quitting can reduce eye complications and may lower relapse risk.
Diets or supplements high in iodine (such as kelp or seaweed products) can trigger or worsen hyperthyroidism in Graves’. Aim for consistent, not excessive, iodine intake unless your clinician advises otherwise.
Ongoing psychosocial stress is associated with a higher likelihood of Graves’ onset and flares. Stress-reduction practices may help stabilize disease activity alongside medical care.
Short, poor-quality, or irregular sleep can disrupt immune balance and may worsen hyperthyroid symptoms in Graves’. A steady sleep schedule can support symptom control and recovery.
Risk prevention
Graves' disease can’t be fully prevented, but you can lower certain risks and catch problems early. Prevention is about lowering risk, not eliminating it completely. Avoiding known triggers and staying alert to early symptoms of Graves' disease can reduce complications and make treatment easier.
Smoking raises the chances of Graves’ disease and makes thyroid eye disease more likely and more severe. Quitting lowers these risks over time and supports better treatment results.
Very high iodine intake can trigger or worsen overactive thyroid in people prone to Graves’. Avoid high‑dose iodine or kelp/seaweed supplements unless your doctor advises them.
Unexplained weight loss, a fast or pounding heartbeat, heat intolerance, nervousness, or hand tremor can be early symptoms of Graves’ disease. If these show up, ask about a thyroid blood test.
If thyroid problems run in your family or you live with another autoimmune condition, ask for periodic thyroid checks. Catching changes early often prevents severe symptoms and eye complications.
Transmission
Graves’ disease is not contagious—you can’t catch it from someone through coughing, kissing, sex, or shared utensils. Graves’ disease does tend to run in families, but how Graves’ disease is inherited is complex: many genes and life factors together raise the chance of developing it, and most relatives never do. During pregnancy, the condition itself isn’t passed to the baby, but thyroid‑stimulating antibodies from the mother can cross the placenta and, rarely, cause temporary thyroid overactivity in the newborn; doctors monitor and treat this if needed. So there can be genetic transmission of Graves’ disease risk, but there is no person‑to‑person transmission.
When to test your genes
Graves’ disease is usually diagnosed by lab tests, but genetic testing can help if you have multiple close relatives with autoimmune thyroid disease or unusually early, severe, or recurrent hyperthyroidism. Consider it if standard tests are inconclusive or you’re planning pregnancy and want tailored risk counseling. Always pair results with an endocrinologist’s guidance.
Diagnosis
For many, the first step comes when everyday activities start feeling harder—like a racing heartbeat while climbing stairs, unexplained weight loss, or feeling overly warm. These changes often prompt a visit to check the thyroid. Doctors usually begin with a careful history, a physical exam, and targeted blood tests to look for an overactive thyroid. If you’re wondering how Graves’ disease is diagnosed, it usually involves a combination of blood tests and imaging tailored to your situation.
Your provider asks about symptoms such as palpitations, heat intolerance, anxiety, and weight loss. They check for a visible or enlarged thyroid, tremor, fast pulse, and eye changes that can suggest Graves’ disease.
Blood tests typically show a low TSH with higher free T4 and/or T3, confirming an overactive thyroid. Results help gauge how severe the overactivity is and guide urgent treatment needs.
Tests for thyroid-stimulating antibodies (often called TSI or TRAb) support Graves’ disease when positive. They can help distinguish Graves’ disease from other causes of hyperthyroidism and are especially useful in pregnancy planning and monitoring.
A small, safe tracer dose shows how much iodine the thyroid absorbs and the uptake pattern. Diffusely high uptake supports Graves’ disease, while different patterns suggest other causes. This test isn’t used during pregnancy or breastfeeding.
Stages of Graves' disease
Graves' disease does not have defined progression stages. Symptoms often build gradually and can flare or settle over time, with the course shaped by treatment choices rather than a strict step-by-step pattern. Doctors usually start with a conversation about your symptoms and medical history, then confirm the diagnosis with an exam and blood tests that look at thyroid hormone levels, TSH, and thyroid antibodies. Sometimes a thyroid scan or an ultrasound is helpful, and repeat blood tests are used to monitor treatment and to spot early symptoms of Graves' disease returning or easing.
Outlook and prognosis
Looking at the long-term picture can be helpful. For most people with Graves’ disease, treatment brings thyroid levels back toward normal and daily life becomes steadier—less racing heart, fewer heat spikes, better sleep, and clearer focus at work or school. Many people ask, “What does this mean for my future?”, and the short answer is that most lead full, active lives once treatment is in place, whether that’s medication, radioiodine, or surgery.
Prognosis refers to how a condition tends to change or stabilize over time. After initial treatment, about one-third to one-half of people who use antithyroid drugs go into remission at some point, but relapses can happen, sometimes months to years later. Eye symptoms linked with Graves’ disease can persist or flare even when thyroid levels are controlled, especially in smokers, but targeted eye care and quitting smoking lower those risks. Serious complications like heart rhythm problems, bone thinning, and, rarely, a dangerous thyroid storm are far less likely with consistent treatment and follow-up; untreated severe hyperthyroidism can be life-threatening, but this is uncommon in settings with access to care.
The outlook is not the same for everyone, but long-term survival for people with treated Graves’ disease is generally comparable to the wider population. Older age, other heart disease, and prolonged uncontrolled thyroid hormone levels carry higher risk, while prompt therapy, managing eye disease early, and not smoking improve outcomes. If you’re wondering about early symptoms of Graves’ disease returning—such as new palpitations, heat intolerance, or unexplained weight loss—check in with your clinician for a lab recheck. Keep regular appointments—small adjustments can improve long-term health.
Long-term effects
Graves' disease can lead to long-term effects that touch energy, eyes, heart, bones, and day-to-day comfort, even after thyroid levels improve. Over years, some people notice changes that come and go, while others settle into a steadier pattern. Long-term effects vary widely, and not everyone experiences the same issues.
Long-term overactivity can persist or flare, keeping metabolism high. This may mean fast heartbeat, heat sensitivity, tremor, and weight loss over time.
Eye tissues can stay inflamed or scar, causing bulging, gritty dryness, or double vision. For some, changes remain even when thyroid levels are normal.
In Graves' disease, long-standing high thyroid hormones raise the risk of irregular heartbeat, especially atrial fibrillation. This can lead to palpitations, shortness of breath, or reduced exercise tolerance.
Years of excess thyroid hormone speed up bone turnover and lower bone density. In Graves' disease, this increases fracture risk, especially in the hips and spine.
How is it to live with Graves' disease?
Living with Graves’ disease can feel like your body’s pace keeps shifting without your say—days of racing heart, heat intolerance, tremor, anxiety, or sleep troubles may be followed by stretches when treatment evens things out. Daily life often involves taking antithyroid medication, beta blockers, or managing post-radioiodine or surgical care, plus regular blood tests to keep thyroid levels in range and adjustments for eye symptoms like dryness, light sensitivity, or bulging. Many find that planning around energy—cooling strategies, breaks, and steady routines—helps, and support from family or coworkers matters when mood, focus, or stamina waver. With a good care plan and clear communication, most people return to work, exercise, and social life, and those around them learn that the shifts are medical, manageable, and not a character change.
Treatment and drugs
Graves’ disease is usually treated by calming the overactive thyroid and easing symptoms that affect daily life, like rapid heartbeat, heat intolerance, anxiety, and sleep trouble. Doctors may start with medicines that block thyroid hormone production, use a short course of beta-blockers to steady heart rate and tremor, or consider definitive options such as radioactive iodine therapy or surgery to remove part or all of the thyroid. Treatment plans often combine several approaches, and the best choice depends on your age, other health conditions, thyroid size, eye involvement, and whether you’re pregnant or planning pregnancy. For Graves’ eye disease, care can include lubricating drops, selenium, steroids, or other targeted therapies, and quitting smoking is strongly recommended. Keep track of how you feel, and share this with your care team, since doses and strategies may need adjustment over time.
Non-drug treatment
Day-to-day, non-drug care can help steady energy, sleep, and eye comfort while you and your care team decide on longer-term steps. Alongside medicines, non-drug therapies can ease symptoms and lower the risk of thyroid eye problems. Some of these approaches also prepare you safely for procedures if they’re needed. Several can help with early symptoms of Graves’ disease, such as heat intolerance, tremor, anxiety, and eye irritation.
A small dose of radioactive iodine is taken by mouth to shrink an overactive thyroid. It is a non-surgical option that often corrects high hormone levels over weeks to months. Your doctor will discuss eye risks and ways to protect your vision if you have thyroid eye disease.
Removing most or all of the thyroid can quickly resolve overactivity. It is considered when other treatments aren’t suitable or when a large goiter causes pressure or swallowing trouble. You’ll need lifelong thyroid hormone after surgery.
Quitting smoking lowers the chance and severity of thyroid eye disease. It also improves healing if you need procedures for Graves’ disease. Support programs and nicotine replacement can raise quit rates.
Avoid high-iodine supplements like kelp and tell clinicians about Graves’ disease before imaging with iodinated contrast. Too much iodine can worsen an overactive thyroid. Ask your care team how to manage unavoidable exposures.
Your genes may have an impact on how drugs work for you
Medicines for Graves’ disease, like methimazole, propylthiouracil, and beta‑blockers, can work differently depending on your genes, which influence how your liver enzymes process drugs and how your immune system behaves. Genetic differences may change dose needs, side‑effect risk, and response.
Pharmacological treatments
Medicines for Graves’ disease aim to calm an overactive thyroid, ease fast heart rate and tremor, and address eye symptoms when they occur. Some act quickly to relieve early symptoms of Graves’ disease like palpitations and anxiety, while others take weeks to bring hormone levels back toward normal. Not everyone responds to the same medication in the same way. Treatment choices may change with pregnancy, eye involvement, other health conditions, and how active the thyroid is.
These antithyroid drugs lower thyroid hormone production and are often the first choice for many adults. Doctors monitor for rare side effects like low white blood cells or rash; report fever or sore throat promptly.
PTU also blocks hormone production and is preferred in early pregnancy and certain emergencies. Because it can affect the liver, regular checks and prompt reporting of fatigue, dark urine, or jaundice are important.
Propranolol, atenolol, or metoprolol can quickly ease shaking, rapid heartbeat, and anxiety. They do not treat the thyroid itself but make day-to-day symptoms more manageable.
Potassium iodide or Lugol’s solution can temporarily “quiet” the thyroid, often before surgery or during severe flares. They are used short-term and usually alongside antithyroid drugs to avoid rebound overactivity.
Genetic influences
Graves’ disease often runs in families, which suggests that genes influence who is more likely to develop it. Family history is one of the strongest clues to a genetic influence. This isn’t a single‑gene condition; many small gene changes together can tilt the immune system toward making antibodies that overstimulate the thyroid. Even so, relatives with the same inherited tendencies may have very different outcomes, because factors like smoking, major stress, pregnancy and the months after delivery, infections, and iodine intake can act as triggers. If a parent or sibling has Graves’ disease, your personal risk is higher than average, but most relatives never develop it. Genetics doesn’t change early symptoms of Graves’ disease—such as a racing heartbeat, tremor, feeling hot, or eye changes—but knowing your family history can help your doctor watch for it and act early if symptoms appear.
Is Graves' disease genetic?
Genetics play a meaningful role in Graves’ disease, raising risk when close relatives are affected. Multiple gene variations influence immune regulation and thyroid function. Still, environment—stress, smoking, infections, iodine exposure—and hormones also shape who develops it and when.
Pharmacogenetics—how genetics influence drug effects
For people treated with antithyroid drugs for Graves’ disease, inherited differences in immune system genes (certain HLA types) have been linked to a higher risk of antithyroid drug–induced agranulocytosis in Graves’ disease, a rare problem where white blood cells drop very low. This signal appears strongest in some East Asian populations; it doesn’t mean you will develop the problem, only that the risk is higher than average. Not every difference in response is genetic, but genes are one piece doctors consider along with your age, other medicines, and liver health. At this time, routine pharmacogenetic testing before starting antithyroid drugs for Graves’ disease isn’t standard in the US or EU, though some centers may test people at higher risk. If you and your clinician choose antithyroid drugs, you’ll still be advised to watch for early signs of low white cells—such as fever or a sore throat—and to stop the drug and get a blood count promptly if they appear. Genes have not been shown to reliably guide radioiodine, surgery, or levothyroxine dosing after definitive treatment, so these decisions rely more on thyroid levels, symptoms, and overall health.
Interactions with other conditions
Graves’ disease often travels alongside other autoimmune conditions such as type 1 diabetes, celiac disease, vitiligo, or pernicious anemia, which can blur symptoms and complicate day-to-day management. Shared genetic variants may explain why certain conditions cluster together. Heart rhythm problems like atrial fibrillation, higher blood pressure, and worsening chest pain can be triggered by untreated thyroid overactivity, so existing heart disease may feel harder to control. Bones can thin faster, increasing fracture risk, especially if osteoporosis is already present. In diabetes, thyroid overactivity can raise blood sugar and insulin needs, while in celiac disease, poor nutrient absorption may mask early symptoms of Graves’ disease. Certain drugs and exposures—iodine contrast used in scans, amiodarone for heart rhythm problems, or stopping steroids—can interact with thyroid activity, so it’s important to coordinate care across specialists when tests or treatments are planned.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden weight loss, a racing heartbeat, and eyes that seemed to “stand out,” often appearing in the same families. In busy markets or churchyards, someone who couldn’t tolerate heat, felt shaky, and looked anxious might have been said to have “nerves,” long before anyone knew the thyroid was involved. Caregivers in the past tried rest, tonics, and herbal mixtures, noticing that symptoms sometimes eased and sometimes flared without warning.
First described in the medical literature as a cluster of symptoms in the early 1800s, Graves’ disease gradually took shape as a distinct condition. Different physicians in Ireland, Germany, and elsewhere described similar patterns around the same time, linking the swollen thyroid in the neck with palpitations and eye changes. Over time, descriptions became more precise as autopsies and early physiology studies connected the thyroid gland to metabolism, temperature control, and energy levels.
With each decade, doctors refined what they saw. By the late 19th and early 20th centuries, surgeons learned that carefully removing part of the thyroid could calm symptoms, though risks were high before modern anesthesia and infection control. Iodine, then antithyroid drugs, and later radioactive iodine offered safer, more reliable ways to bring an overactive thyroid back into balance. These treatments reshaped daily life for many living with Graves’ disease, turning a once-dangerous condition into one that could be managed long term.
Advances in genetics and immunology in the mid to late 20th century revealed that Graves’ disease is an autoimmune condition—the immune system mistakenly stimulates the thyroid like a stuck accelerator. Researchers also explained why eye symptoms happen in some people: immune activity affects the tissues behind the eyes, leading to swelling and pressure. Not everyone with Graves’ disease develops these eye changes, and patterns vary by age, sex, smoking status, and other health factors.
In recent decades, awareness has grown that early symptoms of Graves’ disease—such as heat intolerance, sleep trouble, and unintended weight loss—can be subtle and easily mistaken for stress or menopause. Blood tests that measure thyroid hormones and antibodies now allow much earlier, more accurate diagnosis. Imaging helps when needed, but for most, simple lab work confirms the picture.
Looking back helps explain how today’s approach took shape: centuries of observation led to safer treatments, clearer definitions, and shared decision-making. Today, people with Graves’ disease can expect personalized care that balances medicines, radioactive iodine, or surgery with attention to eye health and quality of life—a far cry from the guesswork and high risk of the past.